|
Generic:
|
|
Tenofovir Alafenamide
|
| |
|
Therapeutic Class:
|
| Nucleoside Reverse Transcriptase Inhibitors |
| |
|
Composition:
|
|
Each Hepbest tablet contains 25 mg of Tenofovir Alafenamide
|
| |
|
Description:
|
|
Hepbest is a nucleotide reverse transcriptase inhibitor for the treatment of Chronic Hepatitis B Virus (HBV) infection in adults with compensated liver disease.
|
| |
|
Indications:
|
|
Hepbest Tab is indicated for the treatment of Chronic Hepatitis B Virus (HBV) infection in adults with compensated liver disease.
|
| |
|
Dosage:
|
|
Recommended Dosage In Adults:
The recommended dosage of HEPBEST is 25 mg (one tablet) taken orally once daily with food.
|
| |
|
Presentations:
|
- Hepbest Tab 25 mg is available in bottle of 30’s.
|
|
|
